As the world’s most widely utilized TLR4-based adjuvant in clinical practice, our technology has powered a diverse portfolio of licensed vaccines.1 Approved Oncology Vaccine.2 Approved Allergy Vaccines.4 Approved Human Infectious Disease VaccinesQuality level: Research grade / GMP grade_x000D_